A carregar...

Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins

E5531, a novel synthetic lipid A analogue, antagonizes the toxic effects of lipopolysaccharide, making it a potential intravenously administered therapeutic agent for the treatment of sepsis. This report describes the distribution of E5531 in human blood and its activity when it is associated with d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rose, Jeffrey R., Mullarkey, Maureen A., Christ, William J., Hawkins, Lynn D., Lynn, Melvyn, Kishi, Yoshito, Wasan, Kishor M., Peteherych, Kathy, Rossignol, Daniel P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2000
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC89718/
https://ncbi.nlm.nih.gov/pubmed/10681310
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!